These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1678971)

  • 21. [Portal hypertension].
    Marbet UA
    Praxis (Bern 1994); 1995 May; 84(19):555-60. PubMed ID: 7792464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological treatment of portal hypertension.
    Patch D; Burroughs AK
    Prog Liver Dis; 1995; 13():269-92. PubMed ID: 9224506
    [No Abstract]   [Full Text] [Related]  

  • 23. [Indications for beta blockers besides coronary disease and arterial hypertension].
    Vetterl F
    Soins Cardiol; 1985; (28-29):25-30. PubMed ID: 2865813
    [No Abstract]   [Full Text] [Related]  

  • 24. [Correction of portal hypertension by beta-adrenoblockers (atenolol and metoprolol) and inhibitors of ACE (lisinopril and enalapril) in liver cirrhosis].
    Lazebnik LB; Mikheeva OM; Toporkov AS; Komissarenko IA; Vasnev OS; Fedulenkova LV
    Eksp Klin Gastroenterol; 2007; (5):57-66. PubMed ID: 18389599
    [No Abstract]   [Full Text] [Related]  

  • 25. [The effect of propranolol on portal hypertension].
    Kovacević N; Tomić D; Perisić-Savić M; Grbić R
    Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():62-4. PubMed ID: 18193814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.
    Abraldes JG; Albillos A; Bañares R; Turnes J; González R; García-Pagán JC; Bosch J
    Gastroenterology; 2009 May; 136(5):1651-8. PubMed ID: 19208350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Portal-systemic encephalopathy and gastrointestinal bleeding after cardioselective beta-blocker (metoprolol) administration to patients with portal hypertension.
    Uribe M; Orozco H; Morán S; Guevara L; Poo JL; Vargas-Vorackova F
    Arch Med Res; 1995; 26(3):221-6. PubMed ID: 8580671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Betablocker, hepatic functions and confusion.
    Bhalla A
    J Assoc Physicians India; 1999 Feb; 47(2):254-5. PubMed ID: 10999112
    [No Abstract]   [Full Text] [Related]  

  • 29. Vascular liver disorders (II): portal vein thrombosis.
    Hoekstra J; Janssen HL
    Neth J Med; 2009 Feb; 67(2):46-53. PubMed ID: 19299846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Portal hypertension. Update on pathophysiology and management.
    Chatila R
    J Med Liban; 2001; 49(2):101-5. PubMed ID: 11910964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preventing the development of varices in cirrhosis.
    Garcia-Tsao G
    J Clin Gastroenterol; 2007; 41 Suppl 3():S300-4. PubMed ID: 17975480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beta-adrenergic blockers for portal hypertension. Lessons from animal models.
    Sikuler E
    J Hepatol; 1991 Mar; 12(2):133-5. PubMed ID: 1675643
    [No Abstract]   [Full Text] [Related]  

  • 33. [Drug therapy and prevention of hemorrhage in esophageal and gastric varices].
    Kitsenko EA; Peresta IuIu
    Klin Med (Mosk); 1995; 73(2):12-6. PubMed ID: 7541875
    [No Abstract]   [Full Text] [Related]  

  • 34. Beta-blockers in the prevention of gastrointestinal bleeding.
    Lebrec L
    Rev Invest Clin; 1990 Jul; 42 Suppl():159-64. PubMed ID: 19256157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pharmacological therapy of portal hypertension].
    Miotti T; Reichen J
    Schweiz Med Wochenschr; 1985 Oct; 115(42):1468-75. PubMed ID: 2866582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic venous pressure gradient: to measure or not to measure, that is the question.
    Sanyal AJ
    Hepatology; 2000 Nov; 32(5):1175-6. PubMed ID: 11050073
    [No Abstract]   [Full Text] [Related]  

  • 37. [Pharmacologic treatment of portal hypertension].
    Drazná E
    Vnitr Lek; 1996 Oct; 42(10):700-4. PubMed ID: 8975462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [New trends in the treatment of hemodynamic disorders in liver cirrhosis].
    Vorob'ev LP; Maev IV
    Klin Med (Mosk); 1991 Sep; 69(9):11-4. PubMed ID: 1687073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disagreement between acute and chronic haemodynamic effects of nadolol in cirrhosis: a pathophysiological interpretation.
    Merkel C; Bolognesi M; Sacerdoti D; Bombonato G; Cavasin L; Gatta A
    Aliment Pharmacol Ther; 2005 Sep; 22(5):433-9. PubMed ID: 16128681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of pharmacological agents on portal hypertension: a haemodynamic appraisal.
    Bosch J
    Clin Gastroenterol; 1985 Jan; 14(1):169-84. PubMed ID: 2859134
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.